Biblio
Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery. Cells. 2024;13(3).
. Advances in the management of higher-risk myelodysplastic syndromes: future prospects. Leuk Lymphoma. 2024:1-12.
. Advances in the multimodal analysis of the 3D chromatin structure and gene regulation. Exp Mol Med. 2024.
. Advances in the ocular complications after hematopoietic stem cell transplantation. Ann Hematol. 2024.
. Advances in the role of GPX3 in ovarian cancer (Review). Int J Oncol. 2024;64(3).
. Advances in the study of tissue-engineered retinal pigment epithelial cell sheets. Regen Ther. 2024;27:419-433.
. Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells. Curr Pharm Des. 2024.
. Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia. Blood Rev. 2024:101208.
. Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models. J Psychiatry Neurosci. 2024;49(2):E109-E125.
. Advances in Thyroid Organoids Research and Applications. Endocr Res. 2024:1-6.
. Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy. Stem Cell Rev Rep. 2024.
. Advances in understanding and management of Erdheim-Chester disease. Life Sci. 2024:122692.
. Advancing Cardiomyocyte Maturation: Current Strategies and Promising Conductive Polymer-based Approaches. Adv Healthc Mater. 2024:e2303288.
. Advancing cell-based therapy in sepsis: An anesthesia outlook. Chin Med J (Engl). 2024.
. Advancing diabetes treatment: the role of mesenchymal stem cells in islet transplantation. Front Immunol. 2024;15:1389134.
. Advancing precision in histocompatibility and immunogenetics: a comprehensive review of the UCLA exchange program. Front Genet. 2024;15:1352764.
. . Advancing Tissue Damage Repair in Geriatric Diseases: Prospects of Combining Stem Cell-Derived Exosomes with Hydrogels. Int J Nanomedicine. 2024;19:3773-3804.
. The advantages of multi-level omics research on stem cell-based therapies for ischemic stroke. Neural Regen Res. 2024;19(9):1998-2003.
. Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs. Sci Rep. 2024;14(1):12654.
. Adverse effects of ferroptotic therapy: mechanisms and management. Trends Cancer. 2024.
. The adverse effects of vitrification on mouse embryo development and metabolic phenotype in offspring. FASEB J. 2024;38(1):e23372.
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities. Transplant Cell Ther. 2024.
. .